Tissue distribution and radiation dosimetry of astatine-211-labeled chimeric 81C6, an α-particle-emitting immunoconjugate
- 30 April 1997
- journal article
- Published by Elsevier BV in Nuclear Medicine and Biology
- Vol. 24 (3), 255-261
- https://doi.org/10.1016/s0969-8051(97)00060-7
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Chimeric anti-tenascin antibody 81C6: Increased tumor localization compared with its murine parentNuclear Medicine and Biology, 1996
- Specific absorbed fractions of energy from internal photon sources in brain tumor and cerebrospinal fluidMedical Physics, 1995
- Quantitation of 211At in small volumes for evaluation of targeted radiotherapy in animal modelsNuclear Medicine and Biology, 1995
- Phase I studies of treatment of malignant gliomas and neoplastic meningitis with131I-radiolabeled monoclonal antibodies anti-tenascin 81C6 and anti-chondroitin proteoglycan sulfate Me1-14 F (ab?)2-a preliminary reportJournal of Neuro-Oncology, 1995
- Preparation and quality control of 211At‐labelled and 125I‐labelled monoclonal antibodies. Biodistribution in mice carrying human osteosarcoma xenograftsJournal of Labelled Compounds and Radiopharmaceuticals, 1994
- Generation and characterization of a mouse/human chimeric antibody directed against extracellular matrix protein tenascinJournal of Neuroimmunology, 1994
- Preparation and evaluation of para-[211At]astatobenzoyl labeled anti-renal cell carcinoma antibody A6H F(ab′)2. In vivo distribution comparison with para-[125I]iodobenzoyl labeled A6H F(ab′)2Nuclear Medicine and Biology, 1993
- G2M arrest and apoptosis in murine T lymphoma cells following exposure to 212Bi alpha particle irradiationNuclear Medicine and Biology, 1993
- The in Vitro Radiobiology of Astatine-211 DecayRadiation Research, 1986
- Is cerebrospinal fluid the major avenue for the removal of 5-hydroxyindoleacetic acid from the brain?Neuropharmacology, 1973